KR20210065637A - Composition for improving hangover cure and alcoholic liver injury comprising pericarp of Areca catechu L and and Ledebouriella seseloides - Google Patents
Composition for improving hangover cure and alcoholic liver injury comprising pericarp of Areca catechu L and and Ledebouriella seseloides Download PDFInfo
- Publication number
- KR20210065637A KR20210065637A KR1020190154623A KR20190154623A KR20210065637A KR 20210065637 A KR20210065637 A KR 20210065637A KR 1020190154623 A KR1020190154623 A KR 1020190154623A KR 20190154623 A KR20190154623 A KR 20190154623A KR 20210065637 A KR20210065637 A KR 20210065637A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- windbreak
- pericarp
- ethanol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 206010019133 Hangover Diseases 0.000 title claims abstract description 10
- 206010067125 Liver injury Diseases 0.000 title abstract description 16
- 231100000753 hepatic injury Toxicity 0.000 title abstract description 10
- 244000080767 Areca catechu Species 0.000 title abstract description 6
- 235000006226 Areca catechu Nutrition 0.000 title abstract description 5
- 241000229182 Ledebouriella seseloides Species 0.000 title abstract description 4
- 230000001476 alcoholic effect Effects 0.000 title abstract 2
- 239000000284 extract Substances 0.000 claims abstract description 58
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims description 10
- 208000022309 Alcoholic Liver disease Diseases 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 19
- 230000001154 acute effect Effects 0.000 abstract description 12
- 230000006698 induction Effects 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 230000004060 metabolic process Effects 0.000 abstract description 8
- 230000003859 lipid peroxidation Effects 0.000 abstract description 7
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 231100000234 hepatic damage Toxicity 0.000 abstract description 6
- 230000008818 liver damage Effects 0.000 abstract description 6
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 abstract description 4
- 239000003440 toxic substance Substances 0.000 abstract description 3
- 231100000167 toxic agent Toxicity 0.000 abstract description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 abstract 1
- 238000002156 mixing Methods 0.000 description 11
- 241000863480 Vinca Species 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000000469 ethanolic extract Substances 0.000 description 6
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000250129 Trigonella foenum graecum Species 0.000 description 2
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 2
- 229910000476 molybdenum oxide Inorganic materials 0.000 description 2
- PQQKPALAQIIWST-UHFFFAOYSA-N oxomolybdenum Chemical compound [Mo]=O PQQKPALAQIIWST-UHFFFAOYSA-N 0.000 description 2
- 210000004303 peritoneum Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- DNJFTXKSFAMXQF-UHFFFAOYSA-N Arecaidine Chemical compound CN1CCC=C(C(O)=O)C1 DNJFTXKSFAMXQF-UHFFFAOYSA-N 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N Glycerol trihexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 240000008154 Piper betle Species 0.000 description 1
- 235000008180 Piper betle Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000218206 Ranunculus Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241001180873 Saposhnikovia divaricata Species 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000037326 chronic stress Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 대복피와 방풍의 혼합추출물을 이용한 숙취해소 및 알코올성 간손상 개선용 조성물에 관한 것이다.The present invention relates to a composition for relieving a hangover and improving alcoholic liver damage using a mixed extract of daabbokki and windbreak.
간은 인간의 신체장기 중 생체 내 대사가 가장 활발하게 일어나는 장기이다. 간은 소화계통으로 분류되지만 실제로는 탄수화물 대사, 아미노산 및 단백질 대사, 지방 대사, 담즙산 및 빌리루빈 대사, 비타민 및 무기질 대사, 호르몬 대사, 해독 작용 및 살균 작용 등 우리 몸에서 일어나는 거의 모든 일에 관여한다. The liver is the organ in which metabolism in the body occurs most actively among human body organs. Although the liver is classified as a digestive system, it is actually involved in almost everything that happens in our body, including carbohydrate metabolism, amino acid and protein metabolism, fat metabolism, bile acid and bilirubin metabolism, vitamin and mineral metabolism, hormone metabolism, detoxification and bactericidal action.
간은 인체 내 소화기계와 전신순환계 사이에 위치하면서 외부에서 들어온 생체 외 물질로부터 전신을 방어하는 기능을 수행하고 있다. 생체 내로 들어온 생체 외 물질은 일단 간을 통과하게 되므로 간은 영양소 이외에도 많은 독성물질에 노출될 위험이 다른 장기보다 많아 그만큼 손상될 확률도 매우 높다. 그러나 간은 재생능력이 우수한 장기로 약간의 손상이 있을 경우에는 충분히 정상으로 회복되지만, 손상이 지속될 경우에는 간 조직의 일부가 완전히 파괴되고 간 기능도 저하되는 등 정상 간으로의 회복이 어려운 상태가 된다. 이러한 간 손상이 만성화되면 그 원인에 상관없이 간 섬유화 또는 간경화, 간암으로 진행된다.The liver is located between the digestive system and the systemic circulatory system in the human body, and performs the function of defending the whole body from external substances introduced from the outside. Since ex vivo substances that enter the body pass through the liver once, the liver has a higher risk of being exposed to many toxic substances in addition to nutrients than other organs, so the probability of damage is very high. However, the liver is an organ with excellent regenerative ability, and if there is a slight damage, it recovers sufficiently to normal, but if the damage continues, a part of the liver tissue is completely destroyed and the liver function is reduced. do. When such liver damage becomes chronic, it progresses to liver fibrosis, cirrhosis, or liver cancer regardless of the cause.
한편, 간 손상을 유발하는 원인으로는 스트레스성 만성피로, 지방성분이 포함된 음식 또는 알콜의 과다섭취, 바이러스의 감염, 각종 약품과 같은 유해물질, 영양부족 등 다양하다.On the other hand, there are various causes of liver damage, such as chronic stress-induced fatigue, excessive consumption of food or alcohol containing fat, viral infection, harmful substances such as various drugs, and malnutrition.
이러한 간손상에 대한 치료효과가 우수하며, 대량 또는 장기간 투여시에도 부작용이 없는 천연물을 이용한 새로운 간질환 치료제의 개발이 요구된다.It is excellent in the therapeutic effect on such liver damage, and there is a need to develop a new therapeutic agent for liver disease using a natural product that does not have side effects even when administered in large quantities or for a long period of time.
대복피는 종려과에 속하는 교목인 빈랑(Areca catecthu L)의 과피로서, 빈랑의 종자에는 알칼로이드 성분인 아레콜린(arecoline), 아레카이닌(arecaine), 구바신(guvacin)이 함유되어 있고, 지방산의 미리스틴산(myristin acid), 팔미틴산(palmitin acid) 등의 성분이 함유된 것으로 알려져 있다(정보섭 및 신민교 저, 도해향약(생약)대사전, 영림사, pp 272-274, 1998). 대복피는 약간 특이한 냄새가 있으며 맛은 맵고 조금 떫으며 성질은 약간 따듯하다. 대복피는 기를 내려 가슴과 배가 답답한 것, 부종, 창만에 쓰이며 대소변을 잘 보게 하고, 약리작용으로는 빈랑의 기생충 구제작용이 보고되었다. The betel rind is the pericarp of Areca catecthu L, a tree belonging to the palm family, and the seeds of betel nut contain arecoline, arecaine, and guvacin, which are alkaloids, and myristine of fatty acids. It is known to contain ingredients such as myristin acid and palmitin acid (by Bo Bo-seop and Shin Min-gyo, Dohaehyangyak (Cerbal Medicine) Metabolism , Youngrimsa, pp 272-274, 1998). It has a slightly peculiar smell, and the taste is spicy and slightly astringent, and the nature is slightly warm. Daebokpi is used for lowering the qi and is used for chest and stomach stuffiness, edema, and constipation, and it is reported that betel nut has a parasite extermination effect as a pharmacological action.
방풍은 미나리과에 속하는 3년생 초목인 방풍(Ledebouriella seseloides WOLF. = Siler divaricatum (TURCZ.) BENTH)의 방풍 및 갯기름나물의 동속식물의 뿌리이며, 정유, 만니톨(mannitol), 고미배당체 등의 성분이 함유된 것으로 알려져 있다(정보섭 및 신민교 저, 도해향약(생약)대사전, 영림사, pp 428, 1998). 방풍은 중국 북동부, 화베이, 내몽골이 원산지이며 약료작물로 재배한다. 한방에서는 두해살이 뿌리를 감기와 두통, 발한과 거담에 약으로 쓰며, 대용품으로 갯기름나물·기름나물·갯방풍을 쓰기도 한다. 한국·중국·우수리강·몽골·시베리아 등지에 분포한다. Windbreak is the windbreak of Ledebouriella seseloides WOLF. = Siler divaricatum (TURCZ.) BENTH, a three-year-old plant belonging to the family Buttercup, and the root of the flora and fauna, and contains essential oils, mannitol, bitter glycosides, etc. It is known to contain (both Bo-seop and Shin Min-gyo, Dohaehyangyak (herbal medicine) dictionary , Youngrimsa, pp 428, 1998). Windbreak is native to northeastern China, Hebei, and Inner Mongolia, and is cultivated as a medicinal crop. In oriental medicine, the biennial root is used as medicine for colds, headaches, sweating and expectoration. It is distributed in Korea, China, Usuri River, Mongolia, and Siberia.
본 발명은 천연약재인 대복피와 방풍을 혼합하여 추출한 혼합추출물을 사용하여 숙취해소와 알코올성 간손상을 효과적으로 개선할 수 있는 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a composition that can effectively improve hangover relieving and alcoholic liver damage by using a mixed extract extracted by mixing daebokki, which is a natural drug, and windbreak.
상기 목적을 달성하기 위하여, 본 발명은 대복피와 방풍의 혼합추출물을 유효성분으로 함유하는 숙취해소 및 알코올성 간손상 개선용 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for relieving a hangover and improving alcoholic liver damage, which contains a mixed extract of daabbokki and windbreak as an active ingredient.
상기 조성물에서, 대복피와 방풍은 1:1의 중량비로 혼합된 것임이 바람직하다.In the composition, it is preferable that the cover and windbreak are mixed in a weight ratio of 1:1.
상기 조성물에서, 상기 추출물은 70% 에탄올을 추출용매로 사용하여 추출한 것임이 바람직하다.In the composition, the extract is preferably extracted using 70% ethanol as an extraction solvent.
상기 조성물에서, 상기 대복피와 방풍의 혼합추출물은,In the composition, the mixed extract of the daebokgi and windbreak,
대복피와 방풍의 혼합물을 8~12배(v/w)의 70% 에탄올에 넣어 55~65℃에서 20~28시간 동안 침지시키는 단계; 침지 후 추출액을 수득하는 단계; 수득한 추출액을 여과하는 단계; 및 여과된 추출액을 감압농축 및 건조시키는 단계를 포함하는 방법에 의하여 제조된 것임이 바람직하다.Putting a mixture of robes and windbreaks in 8-12 times (v/w) 70% ethanol and immersing them at 55-65° C. for 20-28 hours; obtaining an extract after immersion; filtering the obtained extract; And it is preferably prepared by a method comprising the step of concentrating and drying the filtered extract under reduced pressure.
본 발명의 대복피와 방풍의 혼합추출물을 함유하는 조성물은 항산화효과가 우수하고, 급성 알코올 투여에 의한 간손상 유도 모델에서 확인되는 바와 같이 혈중 알코올 농도를 낮추고 알코올 대사과정에서 생성되는 독성물질인 아세트알데하이드를 분해하는 아세트알데하이드 탈수소효소 활성을 높여 주며, 알코올 투여로 인한 지질과산화를 감소시키는 효과가 있다.The composition containing the mixed extract of periwinkle and fenugreek of the present invention has excellent antioxidant effect, lowers blood alcohol concentration as confirmed in the liver damage induction model by acute alcohol administration, and acetone, a toxic substance produced in the process of alcohol metabolism It increases the activity of acetaldehyde dehydrogenase that decomposes aldehydes and has the effect of reducing lipid peroxidation caused by alcohol administration.
따라서 본 발명의 조성물은 숙취해소 및 알코올성 간손상 개선에 효과적으로 사용될 수 있다. Therefore, the composition of the present invention can be effectively used to relieve hangover and improve alcoholic liver damage.
도 1은 급성 알코올 투여에 의한 간손상 유도 모델에서 대복피와 방풍의 혼합비율에 따라 혼합추출물이 혈중 알코올 농도와 ALDH 활성에 미치는 효과를 비교한 결과이다.
도 2는 급성 알코올 투여에 의한 간손상 유도 모델에서 추출용매에 따라 대복피와 방풍의 혼합추출물이 혈중 알코올 농도와 ALDH 활성에 미치는 효과를 비교한 결과이다.
도 3은 대복피와 방풍의 혼합추출물의 항산화효능을 대복피 및 방풍의 단독 추출물과 비교한 결과이다.
도 4는 급성 알코올 투여에 의한 간손상 유도 모델에서 대복피와 방풍의 혼합추출물이 지질과산화에 미치는 효과를 대복피 및 방풍의 단독 추출물과 비교한 결과이다.1 is a result of comparing the effect of a mixed extract on blood alcohol concentration and ALDH activity according to the mixing ratio of daabapki and windbreak in a liver injury induction model by acute alcohol administration.
Figure 2 is a result of comparing the effect of a mixed extract of daabbokki and Bangpung on blood alcohol concentration and ALDH activity according to the extraction solvent in a liver injury induction model by acute alcohol administration.
Figure 3 is a result of comparing the antioxidant effect of the extract of the mixed extract of daabbokki and periwinkle with the single extract of daabbokki and bangpung.
4 is a result of comparing the effect of a mixed extract of daabbokki and bangpung on lipid peroxidation in a liver injury induction model by acute alcohol administration with a single extract of daabbokki and bangpung.
본 발명은 대복피와 방풍의 혼합추출물을 유효성분으로 함유하는 숙취해소 및 알코올성 간손상 개선용 조성물에 관한 것이다. The present invention relates to a composition for relieving a hangover and improving alcoholic liver damage containing a mixed extract of abalone and fenugreek as an active ingredient.
대복피와 방풍은 1:2 내지 2:1의 중량비로 혼합하여 추출하는 것이 바람직하며, 1:1의 중량비로 혼합하여 추출하는 것이 특히 바람직하다.It is preferable to extract by mixing the robes and windbreaks in a weight ratio of 1:2 to 2:1, and it is particularly preferable to extract by mixing them in a weight ratio of 1:1.
추출시 추출용매로는 70% 에탄올을 사용하는 것이 바람직하다. 추출방법으로는 추출에 통상적으로 사용되는 방법을 사용할 수 있다.It is preferable to use 70% ethanol as an extraction solvent during extraction. As the extraction method, a method commonly used for extraction may be used.
상기 대복피와 방풍의 혼합추출물은, 대복피와 방풍의 혼합물을 8~12배(v/w)의 70% 에탄올에 넣어 55~65℃에서 20~28시간 동안 침지시키고, 침지 후 추출액을 수득하고, 수득한 추출액을 여과하고, 여과된 추출액을 감압농축 및 건조시켜 제조하는 것이 보다 바람직하다.The mixed extract of the periwinkle and windbreak is put in 8-12 times (v/w) 70% ethanol and immersed at 55-65° C. for 20-28 hours, and the extract is obtained after immersion It is more preferable to prepare by filtering the obtained extract and concentrating and drying the filtered extract under reduced pressure.
침지하여 추출액을 얻는 단계는 2~3회 반복할 수 있으며, 반복하는 경우 얻어진 추출액은 함께 모아 이후 여과과정을 거친다.The step of obtaining the extract by immersion can be repeated 2-3 times, and in the case of repeating, the obtained extract is collected together and then subjected to a filtration process.
본 발명의 조성물은 숙취해소 및 알코올성 간손상 개선효과가 우수하므로, 숙취해소 및 알코올성 간손상 개선을 위한 약학적 조성물, 건강식품 등에 이용될 수 있다. Since the composition of the present invention is excellent in the effect of relieving hangover and improving alcoholic liver damage, it can be used in pharmaceutical compositions, health foods, etc. for hangover relieving and improvement of alcoholic liver damage.
이하 실시예를 통해 본 발명을 보다 상세하게 설명한다. 이들 실시예는 본 발명을 예시하는 것으로서 본 발명의 범위가 이에 한정되는 것은 아니다.The present invention will be described in more detail with reference to the following examples. These examples illustrate the present invention, but the scope of the present invention is not limited thereto.
<실시예 1><Example 1>
(주)휴먼허브(http://www.humanherb.co.kr/)에서 구입한 대복피와 방풍을 1:1의 중량비로 혼합한 혼합물 100g을 70% 에탄올 1,000㎖에 60℃에서 24시간 동안 침지시켰다. 100 g of a mixture obtained by mixing robes and windbreaks purchased from Human Hub (http://www.humanherb.co.kr/) in a 1:1 weight ratio in 1,000 ml of 70% ethanol at 60°C for 24 hours immersed.
침지 후 실온에서 추출액을 수득하고, 다시 70% 에탄올 1,000㎖를 가하여 2회 더 추출하여 추출액을 모았다.After immersion, an extract was obtained at room temperature, and 1,000 ml of 70% ethanol was added thereto and extracted twice more to collect the extract.
모은 추출액을 여과하고, 여과한 여과물을 감압 회전농축기(Vaccum rotary evaporator; 일본 Nihon Seiko사, VR-205c)로 용매를 증발시키는 감압 농축 및 건조과정을 통하여 70% 에탄올 추출물을 얻었다.The collected extract was filtered, and the filtered filtrate was concentrated under reduced pressure to evaporate the solvent using a vacuum rotary evaporator (Nihon Seiko, Japan, VR-205c) and dried to obtain a 70% ethanol extract.
<실시예 2><Example 2>
대복피와 방풍을 1:2의 중량비로 혼합한 혼합물 100g을 원료로 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 70% 에탄올 추출물을 얻었다.A 70% ethanol extract was obtained in the same manner as in Example 1, except that 100 g of a mixture obtained by mixing sagebrush and windbreak in a weight ratio of 1:2 was used as a raw material.
<실시예 3><Example 3>
대복피와 방풍을 2:1의 중량비로 혼합한 혼합물 100g을 원료로 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 70% 에탄올 추출물을 얻었다.A 70% ethanol extract was obtained in the same manner as in Example 1, except that 100 g of a mixture obtained by mixing robes and windbreaks in a weight ratio of 2:1 was used as a raw material.
<비교예 1><Comparative Example 1>
대복피 100g을 원료로 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 70% 에탄올 추출물을 얻었다.A 70% ethanol extract was obtained in the same manner as in Example 1, except that 100 g of periwinkle was used as a raw material.
<비교예 2><Comparative Example 2>
방풍 100g을 원료로 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 70% 에탄올 추출물을 얻었다.A 70% ethanol extract was obtained in the same manner as in Example 1, except that 100 g of windbreak was used as a raw material.
<비교예 3><Comparative Example 3>
추출용매로 열수를 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 열수 추출물을 얻었다.A hot water extract was obtained in the same manner as in Example 1, except that hot water was used as the extraction solvent.
<실험예 1><Experimental Example 1>
급성 알코올 투여에 의한 간손상 유도 모델에서 대복피와 방풍의 혼합비율별 효과Effect by mixing ratio of abalone and windbreak in a liver injury induction model by acute alcohol administration
실험동물은 Sprague-Dawley 래트(rat) 7주령 수컷을 사용하였다. As the experimental animal, a 7-week-old male Sprague-Dawley rat was used.
실험시료로는 대복피와 방풍의 1:1 혼합추출물(실시예 1), 대복피와 방풍의 1:2 혼합추출물(실시예 2), 대복피와 방풍의 2:1 혼합추출물(실시예 3), 대복피 단독 추출물(비교예 1) 및 방풍 단독 추출물(비교예 2)을 생리식염수에 용해시켜 사용하였으며, 200mg/kg 농도로 0.5㎖씩 경구투여하였다. 양성대조군(PC)에는 생리식염수를을 동량 경구투여하였다.As an experimental sample, a 1:1 mixed extract (Example 1), a 1:2 mixed extract (Example 2), a biceps skin and a windbreak, a 2:1 mixed extract (Example 3) ), a single extract of periwinkle (Comparative Example 1) and a single extract of windbreak (Comparative Example 2) were dissolved in physiological saline and administered orally at a concentration of 200 mg/kg by 0.5 ml each. The same amount of physiological saline was orally administered to the positive control group (PC).
실험시료를 투여하고 30분 후 체중 kg당 4g의 50% 에탄올을 경구투여하여 급성 알코올 투여에 의한 간손상을 유도하여 급성 알코올 투여에 의한 간손상 유도 모델(in vivo)을 얻었다.30 minutes after administration of the experimental sample, 4 g of 50% ethanol per kg of body weight was orally administered to induce liver damage by acute alcohol administration, thereby obtaining a liver injury induction model (in vivo) by acute alcohol administration.
상기 급성 알코올 투여에 의한 간손상 유도 모델에서 에탄올을 경구투여하고 45분 후, 3시간 후 및 8시간 후에 복부대정맥에서 채혈하였다. In the liver injury induction model by the acute alcohol administration, ethanol was orally administered, and blood was collected from the abdominal vena cava after 45 minutes, 3 hours, and 8 hours.
혈액은 실온에서 30분 동안 방치한 후 원심분리(3,000rpm, 10분)하여 혈청만 채취하여 에탄올 키트(ethanol assay kit)를 사용하여 혈중 알코올 농도(ethanol in serum)를 분석하고 아세트알데하이드 탈수소효소 키트(acetaldehyde assay kit)를 이용하여 ALDH(아세트알데하이드 탈수소효소) 활성을 분석하였다. 그 결과를 도 1에 나타내었다.The blood was left at room temperature for 30 minutes and then centrifuged (3,000 rpm, 10 minutes) to collect only the serum, and analyze the ethanol in serum using an ethanol assay kit, followed by an acetaldehyde dehydrogenase kit. (acetaldehyde assay kit) was used to analyze ALDH (acetaldehyde dehydrogenase) activity. The results are shown in FIG. 1 .
도 1에서와 같이, 급성 알코올 투여에 의한 간손상 유도 모델에서, 에탄올 투여군은 높은 혈중 알코올 농도를 나타내었고, 대복피와 방풍의 1:1 혼합추출물을 투여한 실험군은 대복피 단독 추출물과 방풍 단독 추출물을 투여한 실험군에 비해 혈중 알코올 농도가 각각 60.5%, 105.2% 낮은 것으로 확인되었다. 또한 ALDH 활성도 대복피와 방풍의 1:1 혼합추출물을 투여한 실험군에서 가장 높은 것으로 확인되었다.As shown in FIG. 1, in the liver injury induction model by acute alcohol administration, the ethanol administration group showed a high blood alcohol concentration, and the experimental group administered with a 1:1 mixed extract of daabbokki extract and pericardium alone It was confirmed that the blood alcohol concentration was 60.5% and 105.2% lower, respectively, compared to the experimental group to which the extract was administered. In addition, it was confirmed that the ALDH activity was highest in the experimental group administered with 1:1 mixed extracts of periwinkle and persimmon.
<실험예 2><Experimental Example 2>
급성 알코올 투여에 의한 간손상 유도 모델에서 추출용매에 따른 효과Effect of Extraction Solvent in Acute Alcohol Induction Induction Model
실험시료로 대복피와 방풍의 70% 에탄올 추출물(실시예 1)과 대복피와 방풍의 열수추출물(비교예 3)을 사용한 것을 제외하고는 실험예 1과 동일한 방법으로 실험하였다.Experiments were carried out in the same manner as in Experimental Example 1, except that 70% ethanol extracts of periwinkle and windbreak (Example 1) and hot-water extracts of pericardium and windbreak (Comparative Example 3) were used as experimental samples.
그 결과를 나타낸 도 2에서와 같이, 알코올 투여 후 8시간이 경과된 혈청에서 70% 에탄올을 추출용매로 사용한 추출물이 열수추출물에 비해 혈중 알코올 농도가 약 60.5% 감소하였고 ALDH 활성은 약 52.6% 증가한 것으로 확인되었다. As shown in FIG. 2 showing the results, the extract using 70% ethanol as an extraction solvent in the
<실험예 3><Experimental Example 3>
항산화효능antioxidant effect
본 발명의 대복피와 방풍 혼합추출물의 항산화효능을 다음과 같이 DPPH 분석법, ABTS 라디칼 분석법, FRAP 분석법 및 총페놀 함량으로 확인하였다. The antioxidant effect of the mixed extract of periwinkle and windbreak of the present invention was confirmed by DPPH analysis, ABTS radical analysis, FRAP analysis, and total phenol content as follows.
시료로는 실시예 1의 내복피와 방풍의 혼합추출물, 비교예 1의 대복피 추출물 및 비교예 2의 방풍 추출물을 사용하였다. 대조를 위하여 비타민 C(Vit C)를 사용하였다. As a sample, the mixed extract of the inner peritoneum of Example 1 and the peritoneum extract of Comparative Example 1 and the windbreak extract of Comparative Example 2 were used. Vitamin C (Vit C) was used for control.
(1) DPPH 라디칼 소거 활성(DPPH assay)(1) DPPH radical scavenging activity (DPPH assay)
Blois MS(1958)의 방법에 따라 DPPH에 대한 라디칼 소거 활성을 측정하였다. 각 시료 160㎕에 0.2mM의 DPPH(1,1-diphenyl-2-picrylhydrazyl) 80㎕를 넣어 교반하였다. 교반 후 30분 동안 방치한 다음 마이크로플레이트 판독기(microplate reader)를 사용하여 517㎚에서 흡광도를 측정하였다.The radical scavenging activity for DPPH was measured according to the method of Blois MS (1958). To 160 μl of each sample, 80 μl of 0.2 mM DPPH (1,1-diphenyl-2-picrylhydrazyl) was added and stirred. After stirring, it was allowed to stand for 30 minutes, and then absorbance was measured at 517 nm using a microplate reader.
(2) ABTS 라디칼 소거 활성(ABTS assay)(2) ABTS radical scavenging activity (ABTS assay)
7mM ABTS 용액과 2.45mM 과황화칼륨(potassium persulfate, 최종농도)을 혼합하고 상온에서 빛을 차단한 진탕배양기(shaking incubator)에서 12시간 동안 반응시켜 라디칼을 생성시켰다. 라디칼을 생성시킨 후 415nm에서의 흡광도가 0.7±0.02가 되도록 에탄올(100%)로 희석하였다. 250㎕ ABTS 용액과 28㎕ 시료를 혼합하여 상온에서 5분 동안 반응시킨 후 분광광도계를 사용하여 415nm에서의 흡광도를 측정하였다. 양성대조군(positive control)으로 Trolox를 사용하였다. 측정한 흡광도를 하기 수학식 1로 계산하였다.A 7mM ABTS solution and 2.45mM potassium persulfate (final concentration) were mixed and reacted for 12 hours in a shaking incubator blocked from light at room temperature to generate radicals. After generating radicals, it was diluted with ethanol (100%) so that the absorbance at 415 nm was 0.7±0.02. After mixing 250 μl ABTS solution and 28 μl sample and reacting at room temperature for 5 minutes, absorbance at 415 nm was measured using a spectrophotometer. Trolox was used as a positive control. The measured absorbance was calculated by Equation 1 below.
(3) FRAP 분석(FRAP assay)(3) FRAP assay
산화반응에 의해 TPTZ(Ferric 2,4,6-tripyridyl-s-triazine) 시약에서 2가의 철이 3가로 산화되면서 착색된 생성물로 전환되는 원리를 이용한 분석법이다.This is an analysis method using the principle that iron is oxidized to trivalent in TPTZ (Ferric 2,4,6-tripyridyl-s-triazine) reagent by oxidation reaction and converted into a colored product.
황산제일철(Ferrous sulphate)을 사용하여 1mM 용액 (0.278g FeSO4·7H2O/L)을 제조하여 표준용액으로 사용하였고, FRAP 용액은 300mM 아세테이트 버퍼(pH3.6) 200㎖, 10mM TPTZ 용액 20㎖, 20mM FeCl3용액 20㎖, 멸균수 24㎖를 혼합하여 제조한 후 37℃로 유지하여 사용하였다. 96-웰 플레이트에 웰당 멸균수 170㎕, 표준용액 또는 시료용액 7㎕와 30㎕ FRAP 용액을 혼합한 다음 4분 후 593nm에서 흡광도를 측정하였다. FRAP 수준은 흡광도 값의 표준용액에 대한 선형회귀분석을 통해 산출하였다.A 1 mM solution (0.278 g FeSO 4 .7H 2 O/L) was prepared using ferrous sulphate and used as a standard solution, and the FRAP solution was 300 mM acetate buffer (pH3.6) 200 ml, 10
(4) 총페놀함량(4) Total phenol content
총 페놀 함량은 폴린-시아칼토 분석법(Folin-Ciocalteu assay)으로 측정하였다. 이 방법은 알칼리용액(5~10%의 soluble sodium carbonate)에서 텅스텐산염(tungstate)과 몰리브덴산염(molybdate)의 혼합물을 이용하는 것으로 페놀화합물이 산화되어 O2 -를 형성하고 몰리브덴산염과 반응하여 산화몰리브덴(molybdenum oxide)(MoO4+)을 형성하는데 이렇게 형성된 물질을 750nm에서 측정하였으며, 그 값은 GAE(gallic acid equivalents)로 나타내었다.Total phenol content was determined by Folin-Ciocalteu assay. This method uses a mixture of tungstate and molybdate in an alkaline solution (5-10% soluble sodium carbonate). The phenolic compound is oxidized to form O 2 - and reacts with molybdate to form molybdenum oxide. To form (molybdenum oxide) (MoO 4+ ), the material thus formed was measured at 750 nm, and the value was expressed as gallic acid equivalents (GAE).
(5) 결과(5) Results
항산화효능을 확인한 결과를 도 3에 나타내었다. 도 3의 결과에서와 같이, 항산화와 관련된 주요인자들에 미치는 영향을 실험한 결과, DPPH 라디칼 소거 활성, ABTS 라디칼 소거활성, FRAP 값 및 총페놀함량 모두 대복피와 방풍의 혼합추출물(1:1 비율)이 대복피 및 방풍 단독추출물보다 높은 활성을 나타내었다.The results of confirming the antioxidant effect are shown in FIG. 3 . As shown in the results of Figure 3, as a result of testing the effect on major factors related to antioxidants, the DPPH radical scavenging activity, ABTS radical scavenging activity, FRAP value, and total phenol content were all mixed extracts of Korean radish and windbreak (1:1). ratio) showed a higher activity than the extracts of Daebokpi and Bangpung alone.
<실험예 4><Experimental Example 4>
급성 알코올 투여에 의한 간손상 유도 모델에서 지질과산화에 대한 효과Effects on lipid peroxidation in a liver injury induction model by acute alcohol administration
실험시료로 대복피와 방풍의 1:1 혼합추출물(실시예 1), 대복피 단독 추출물(비교예 1), 방풍 단독 추출물(비교예 2)을 각각 10㎍/㎖, 50㎍/㎖, 100㎍/㎖, 200㎍/㎖의 농도로 사용한 것을 제외하고는 실험예 1과 동일한 방법으로 실험하고, 실험에 사용된 래트 조직내 지질과산화를 다음과 같이 측정하였다. As experimental samples, a 1:1 mixed extract (Example 1), a single extract (Comparative Example 1), and a single extract (Comparative Example 2) of perilla perilla and perilla perforum were 10 µg/ml, 50 µg/ml, 100 µg, respectively. The experiment was conducted in the same manner as in Experimental Example 1 except that it was used at a concentration of μg/ml and 200 μg/ml, and lipid peroxidation in the rat tissue used in the experiment was measured as follows.
간 조직을 관류(perfusion)한 후 간 무게를 측정하였다. 측정된 간조직무게의 10%에 해당하는 차가운 PBS(ice cold PBS)를 넣고, 소니케이터(sonicator)를 이용하여 조직을 현탁시켰다. After the liver tissue was perfused (perfusion), the liver weight was measured. Ice cold PBS corresponding to 10% of the measured liver tissue weight was added, and the tissue was suspended using a sonicator.
현탁액은 10,000×g에서 5분 동안 원심분리하여 상등액을 취하였다. 상등액 50㎕와 0.15M KCl 500㎕를 잘 혼합한 후 20mM FeCl3 100㎕를 첨가하였다. 혼합액은 37℃에서 30분간 배양하고, 반응종료액(0.25N ice-cold HCl + 15%TCA+0.38% TBA+0.05% BHT)을 1㎖ 첨가하여 반응을 종료시켰다. The suspension was centrifuged at 10,000×g for 5 minutes to obtain a supernatant. 50 μl of the supernatant and 500 μl of 0.15M KCl were mixed well, and then 100 μl of 20mM FeCl 3 was added. The mixture was incubated at 37° C. for 30 minutes, and 1 ml of the reaction termination solution (0.25N ice-cold HCl + 15% TCA + 0.38% TBA + 0.05% BHT) was added to terminate the reaction.
90℃에서 30분 동안 배양한 한 후, 10,000×g에서 5분 동안 원심분리를 실시하였다. 원심분리후 얻어진 분홍색 시료물을 분광광도계를 이용하여 535nm에서의 흡광도를 측정하였다. After incubation at 90° C. for 30 minutes, centrifugation was performed at 10,000×g for 5 minutes. The absorbance at 535 nm was measured for the pink sample obtained after centrifugation using a spectrophotometer.
지질과산화값은 FeCl3와 비교한 백분율로 계산하였으며, 그 결과를 도 4에 나타내었다.The lipid peroxidation value was calculated as a percentage compared with FeCl 3 , and the results are shown in FIG. 4 .
도 4에서와 같이, 지질과산화값은 대복피와 방풍의 혼합추출물을 투여한 실험군이 200㎍/㎖ 농도에서 대복피 단독 추출물과 방풍 단독 추출을 투여한 실험군물에 비해 약 30.8%, 43.1% 감소한 것으로 확인되었다. As shown in Figure 4, the lipid peroxidation value of the experimental group administered with the mixed extract of periwinkle and periwinkle was reduced by about 30.8%, 43.1% compared to the experimental group administered with the extract alone and pericardium alone at a concentration of 200 μg/ml. was confirmed to be
Claims (4)
대복피와 방풍은 1:2 내지 2:1의 중량비로 혼합된 것임을 특징으로 하는 조성물.According to claim 1,
The composition, characterized in that the cover and windbreak are mixed in a weight ratio of 1:2 to 2:1.
상기 추출물은 70% 에탄올을 추출용매로 사용하여 추출한 것임을 특징으로 하는 조성물.According to claim 1,
The composition is characterized in that the extract is extracted using 70% ethanol as an extraction solvent.
상기 대복피와 방풍의 혼합추출물은,
대복피와 방풍의 혼합물을 8~12배(v/w)의 70% 에탄올에 넣어 55~65℃에서 20~28시간 동안 침지시키는 단계;
침지 후 추출액을 수득하는 단계;
수득한 추출액을 여과하는 단계; 및
여과된 추출액을 감압농축 및 건조시키는 단계를 포함하는 방법에 의하여 제조된 것임을 특징으로 하는 조성물.
According to claim 1,
The mixed extract of the abalone skin and windbreak,
Putting a mixture of robes and windbreaks in 8-12 times (v/w) 70% ethanol and immersing them at 55-65° C. for 20-28 hours;
obtaining an extract after immersion;
filtering the obtained extract; and
A composition, characterized in that it is prepared by a method comprising the step of concentrating and drying the filtered extract under reduced pressure.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190154623A KR102402228B1 (en) | 2019-11-27 | 2019-11-27 | Composition for improving hangover cure and alcoholic liver injury comprising pericarp of Areca catechu L and and Ledebouriella seseloides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190154623A KR102402228B1 (en) | 2019-11-27 | 2019-11-27 | Composition for improving hangover cure and alcoholic liver injury comprising pericarp of Areca catechu L and and Ledebouriella seseloides |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210065637A true KR20210065637A (en) | 2021-06-04 |
KR102402228B1 KR102402228B1 (en) | 2022-05-25 |
Family
ID=76391763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190154623A KR102402228B1 (en) | 2019-11-27 | 2019-11-27 | Composition for improving hangover cure and alcoholic liver injury comprising pericarp of Areca catechu L and and Ledebouriella seseloides |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102402228B1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060057805A (en) * | 2004-11-24 | 2006-05-29 | 박정휘 | Pharmaceutical composition comprising the crude drug extract for preventing and treating liver disease |
KR100626724B1 (en) | 2004-04-14 | 2006-10-02 | 서울향료(주) | Extract of herbal mixture and pharmaceutical composition for prevention or treatment of liver fibrosis |
KR101393598B1 (en) * | 2013-07-17 | 2014-05-09 | 임춘규 | Healthy food composition for healing a hangover |
KR20140077483A (en) | 2012-12-14 | 2014-06-24 | 강원대학교산학협력단 | Composition for preventing or treating the brain ischemia disease containing extract of glehnia littoralis |
KR20150037204A (en) | 2013-09-30 | 2015-04-08 | 주식회사 오비엠랩 | A composition for wound healing comprising extracts of arecae pericarpium |
KR101731216B1 (en) * | 2016-06-10 | 2017-04-27 | 오삼성 | herbal beverage |
KR20190064558A (en) | 2019-05-31 | 2019-06-10 | 동국대학교 경주캠퍼스 산학협력단 | Pharmaceutical Composition for Preventing Or Treating Of Dry Eye Comprising Extract Of Saposhnikoviae Radix, Galla Rhois, Lophatheri Herba, And Gentianae Scabrae Radix |
-
2019
- 2019-11-27 KR KR1020190154623A patent/KR102402228B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100626724B1 (en) | 2004-04-14 | 2006-10-02 | 서울향료(주) | Extract of herbal mixture and pharmaceutical composition for prevention or treatment of liver fibrosis |
KR20060057805A (en) * | 2004-11-24 | 2006-05-29 | 박정휘 | Pharmaceutical composition comprising the crude drug extract for preventing and treating liver disease |
KR20140077483A (en) | 2012-12-14 | 2014-06-24 | 강원대학교산학협력단 | Composition for preventing or treating the brain ischemia disease containing extract of glehnia littoralis |
KR101393598B1 (en) * | 2013-07-17 | 2014-05-09 | 임춘규 | Healthy food composition for healing a hangover |
KR20150037204A (en) | 2013-09-30 | 2015-04-08 | 주식회사 오비엠랩 | A composition for wound healing comprising extracts of arecae pericarpium |
KR101731216B1 (en) * | 2016-06-10 | 2017-04-27 | 오삼성 | herbal beverage |
KR20190064558A (en) | 2019-05-31 | 2019-06-10 | 동국대학교 경주캠퍼스 산학협력단 | Pharmaceutical Composition for Preventing Or Treating Of Dry Eye Comprising Extract Of Saposhnikoviae Radix, Galla Rhois, Lophatheri Herba, And Gentianae Scabrae Radix |
Non-Patent Citations (1)
Title |
---|
얼음 채운 시원한 포도 먹고 숙취 해소. 문화일보 기사. [online]. 2014.12.16., [2021.05.25. 검색], 인터넷: <URL: http://www.munhwa.com/news/news_print.html?no=2014121601032212000002> 1부.* * |
Also Published As
Publication number | Publication date |
---|---|
KR102402228B1 (en) | 2022-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nain et al. | Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats | |
Khare | Indian herbal remedies: rational Western therapy, ayurvedic, and other traditional usage, Botany | |
Yener et al. | Effects of Urtica dioica L. seed on lipid peroxidation, antioxidants and liver pathology in aflatoxin-induced tissue injury in rats | |
KR100372561B1 (en) | Compositions effective for removing hangover which contains natural herb tea extracts and health supplementing foods containing the same as an effective ingredient | |
Omoregie et al. | Antioxidant properties of methanolic extracts of some Nigerian plants on nutritionally-stressed rats | |
CN102573871A (en) | Antiphlogistic, antioncotic and analgesic chinese herbal composition,preparative method and usage thereof | |
Jimoh et al. | Polyphenolic and biological activities of leaves extracts of Argemone subfusiformis (Papaveraceae) and Urtica urens (Urticaceae) | |
Aja et al. | Comparative phytochemical composition of Cajanus cajan leaf and seed | |
CN113521164B (en) | Tibetan medicine composition with antibacterial effect and preparation method and application thereof | |
KR101986186B1 (en) | Cpmposition for care of dermatic disease comprinsing plant extract | |
KR101431417B1 (en) | The method of oriental composite for treatment of atopy and cancer | |
KR20150075598A (en) | A method for preparation of mixed composition with fermented medical plants extracts | |
Sowmya et al. | An phyto-chemical analysis of seedless amalaki fruit (Emblica officinalis) churna | |
KR100831621B1 (en) | The plant extracts composition for the blood glucose reducing action | |
KR101432746B1 (en) | Mixture extract of yacon(Smallanthus sonchifolius), Torilis japonica and Acorus gramineus, health food composition and cosmetic composition for preventing or improving benign prostatic hyperplasia or alopecia containing the same | |
Jagadeesan et al. | Antioxidant and free radical scavenging activities of common wild greens from Tiruvallur District of Tamil Nadu, India | |
KR102309913B1 (en) | Composition for improving hangover cure and alcoholic liver injury comprising root extract of Rosa multiflora THUNB | |
WO2018035706A1 (en) | Traditional chinese medicine preparation for atopic dermatitis, preparation method therefor and use thereof | |
KR102402228B1 (en) | Composition for improving hangover cure and alcoholic liver injury comprising pericarp of Areca catechu L and and Ledebouriella seseloides | |
Salim et al. | Phytochemical Screening and Therapeutic Effects of Binahong (Anredera cordifolia (Ten.) Steenis) Leaves | |
KR20160068215A (en) | Cosmetic Compositions Including a Natural Extract for Improvement of Acne | |
KR102266729B1 (en) | Composition for improving liver injury and liver disease comprising flower of Rosa rugosa Thunberg and Cinnamomum cassia PRESL | |
Mubarak et al. | Phytochemical and Bioactive Evaluation of Cissus rotundifolia and Maydis stigma Cultivated in Taiz, Yemen | |
Ojieh | Evaluation of Antidiabetic and Antioxidant potential of Nephrolepis unduranta leaves extract in Streptozotocin Induced Diabetic Wistar Rats. | |
KR102621205B1 (en) | An anti-oxidant and anti-inflammatory composition comprising extracts of lacquer tree, fluafomitella fraxinea and kudingcha |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |